Stephen J. Schueler, M.D.

Overview Incidence Risk Factors Symptoms Evaluation Treatment questions for doctor specialist Home Care diet warning signs Prevention vaccine Outlook Complications Transmission Anatomy

Hepatitis A Treatment

There is no cure for hepatitis A. The therapy for hepatitis A is supportive as the illness generally resolves on its own. Liver failure due to hepatitis A is very rare.

Treatment for hepatitis A may include:

Hepatitis A Questions For Doctor

The following are some important questions to ask before and after the treatment of hepatitis A.

Questions to ask before treatment:

  • What are my treatment options?
  • What are the risks associated with treatment?
  • Do I need to stay in the hospital?
    • How long will I be in the hospital?
  • Am I contagious?
    • For how long?
  • What are the complications I should watch for?
  • How long will I be on medication?
  • What are the potential side effects of my medication?
  • Does my medication interact with nonprescription medicines or supplements?
  • Should I take my medication with food?

Questions to ask after treatment:
  • Do I need to change my diet?
  • Are there any medications or supplements I should avoid?
  • When can I resume my normal activities?
  • When can I return to work?
  • How do I avoid passing the infection to others?
  • What else can I do to reduce my risk for complications?
  • What else can I do to reduce my risk for liver disease?
  • How often will I need to see my doctor for checkups?
  • What local support and other resources are available?

Hepatitis A Specialist

Physicians from the following specialties evaluate and treat hepatitis A:

Continue to Hepatitis A Home Care

Last Updated: Dec 15, 2010 References
Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott Gettings, MD
Copyright DSHI Systems, Inc. Powered by: FreeMD - Your Virtual Doctor

PubMed Hepatitis A References
  1. Centers for Disease Control and Prevention (CDC). Positive test results for acute hepatitis A virus infection among persons with no recent history of acute hepatitis--United States, 2002-2004. MMWR Morb Mortal Wkly Rep. 2005 May 13;54(18):453-6. [15889006]
  2. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004 Dec;132(6):1005-22. [15635957]
  3. Murdoch DL, Goa K, Figgitt DP. Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability. Drugs. 2003;63(23):2625-49. [14636084]
  4. Oncu S, Oncu S, Sakarya S. Hepatitis A and B seropositivity among medical students. Health Policy. 2005 Sep 28;74(1):39-45. [16098410]
  5. Saab S, Lee C, Shpaner A, Ibrahim AB. Seroepidemiology of hepatitis A in patients with chronic liver disease. J Viral Hepat. 2005 Jan;12(1):101-5. [15655056]
  6. Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. JAMA. 2005 Jul 13;294(2):194-201. [1601459]
FreeMD is provided for information purposes only and should not be used as a substitute for evaluation and treatment by a physician. Please review our terms of use.